- Exchange: LSE EuropeQS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Snapshot for Merck KGaA (MRK)
| Open: | 122.875 | Day's Range: | 122.875 - 125.500 | Volume: | 3,486 |
|---|---|---|---|---|---|
| Previous Close: | 123.625 | 52wk Range: | 75.785 - 126.750 | 1-Yr Rtn: | +61.07% |
Key Statistics for MRK
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 14.3562 |
| Relative P/E vs. UKX | - |
| Earnings Per Share (EUR) (ttm) | - |
| Est. EPS (EUR) (12/2013) | 8.5590 |
| Est. PEG Ratio | 2.1660 |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 6,092 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 1.38% |
| Cash Dividend (EUR) | 1.7000 |
| Last Dividend | 04/29/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/06/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for MRK
Company Profile & Key Executives for MRK
Merck KGaA is a global pharmaceutical and chemicals company. The Company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for flat screens and the pharmaceutical, food, cosmetics, packaging, and coatings.
| Karl-Ludwig KleyChairman-Mgmt Board/CEO | Matthias ZachertCFO/Member-Mgmt Board |
| Kai BeckmannChief Administration Officer | Bernd ReckmannMember-Mgmt Board |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
MRK News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page